What is Karuna Labs?
Karuna Labs operates at the intersection of neuroscience and digital health, providing the KarunaHOME platform as a scalable alternative to traditional pain management. The company utilizes neuroplasticity-based techniques to help patients retrain their neural pathways, effectively reducing reliance on opioids and surgical interventions. By offering a 12-week structured program, Karuna Labs addresses the critical need for accessible, evidence-based care for chronic pain sufferers. Their business model is uniquely positioned to integrate with health plans and workers' compensation providers, offering a cost-effective, high-engagement solution that improves patient outcomes while reducing long-term healthcare expenditures.
How much funding has Karuna Labs raised?
Karuna Labs has raised a total of $3.1M across 2 funding rounds:
Angel/Seed
$3M
Debt
$136K
Angel/Seed (2019): $3M with participation from AET Fund, Anorak Ventures, Hustle Fund, Baseline Ventures, Correlation Ventures, and Dreamit Ventures
Debt (2021): $136K led by PPP
Key Investors in Karuna Labs
Anorak Ventures
Anorak Ventures is a venture capital firm specializing in deep technology sectors, including artificial intelligence, robotics, and virtual reality, providing strategic support to early-stage innovators.
Baseline Ventures
Baseline Ventures is a prominent firm focused on sports, entertainment, and brand licensing, known for its expertise in creating high-value partnerships and managing global brand assets.
Correlation Ventures
Correlation Ventures utilizes advanced data science to drive rapid, informed investment decisions, supporting companies that aim to disrupt traditional industries through innovation.
What's next for Karuna Labs?
With the recent infusion of capital, Karuna Labs is poised to accelerate its enterprise adoption strategy. The focus will likely shift toward deepening integration with major health insurance providers and expanding the clinical validation of its neuroplasticity protocols. As the company scales, it will likely prioritize the enhancement of its digital coaching infrastructure and the refinement of its data-driven patient monitoring tools. By maintaining a non-pharmacological focus, Karuna Labs is well-positioned to capitalize on the increasing demand for sustainable, patient-centric healthcare solutions that offer measurable clinical efficacy and significant cost savings for institutional payers.
See full Karuna Labs company page
